Connect
MJA
MJA

Clinically significant localised prostate cancer: deciding what will provide the best clinical outcomes

Henry H Woo and Amy Teh
Med J Aust 2021; 214 (6): . || doi: 10.5694/mja2.50983
Published online: 5 April 2021

Prostate cancer specialists working in collegiate, multidisciplinary teams are most likely to provide the best outcomes for patients

In the absence of formal comparative studies, there is no real evidence that the outcomes of surgery or radiotherapy for patients with localised prostate cancer differ significantly. However, most men in Australia with clinically significant localised prostate cancer undergo surgery rather than radiotherapy.

  • Henry H Woo1,2
  • Amy Teh3

  • 1 Sydney Adventist Hospital Clinical School, University of Sydney, Sydney, NSW
  • 2 Chris O’Brien Lifehouse, Sydney, NSW
  • 3 Icon Cancer Centre, Sydney, NSW

Correspondence: henry.woo@sydney.edu.au

Competing interests:

Henry Woo has received speaker’s and advisory board fees from Astellas, Janssen, and Boston Scientific.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.